In pairwise comparisons of glioma samples, two genes (BUB1B, CDC20) showed significant difference between grade II and grade IV (p<0.05), while expression in grade III does not significantly differ from grade II or grade IV for most genes. Here, CDC20 is linked to central nervous system cancer.